RECRUITING

Resilience and Equity in Aging, Cancer, and Health (REACH)

Talk to us

Conditions

Gastric CancerColon CancerEsophageal CancerRectal CancerPancreatic CancerGastrointestinal Cancer

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.

Official Title

Resilience and Equity in Aging, Cancer, and Health (REACH): Promoting Physical Resilience and Cancer Care Equity for Adults Age 70 and Older Diagnosed With Gastrointestinal Malignancy

Quick Facts

Study Start:2022-01-18
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04674267

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients who are age 70+ at time of initial consult at DF/BWCC
  2. * Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors.
  3. * Continuing care at DF/BWCC beyond initial consult visit
  4. * English and Spanish-speaking
  1. * Patients less than age 70 at time of initial consultation appointment with DF/BWCC.
  2. * Patients who are not continuing care at DF/BWCC beyond first consult visit.
  3. * Not proficient in English or Spanish
  4. * Patient who are not considered appropriate for enrollment due to complex medical, social, or other situation as determined by their primary oncology team.
  5. * Participants with psychiatric illness/social situations that would limit compliance with study requirements.

Contacts and Locations

Study Contact

Nadine J McCleary, MD, MPH
CONTACT
877-442-3324
NJ_McCleary@dfci.harvard.edu

Principal Investigator

Nadine J McCleary, MD, MPH
PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute

Study Locations (Sites)

Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
United States

Collaborators and Investigators

Sponsor: Dana-Farber Cancer Institute

  • Nadine J McCleary, MD, MPH, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-01-18
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2022-01-18
Study Completion Date2024-12-31

Terms related to this study

Keywords Provided by Researchers

  • Gastrointestinal cancer

Additional Relevant MeSH Terms

  • Gastric Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Rectal Cancer
  • Pancreatic Cancer
  • Gastrointestinal Cancer